NCT03393429 is a NA clinical trial of DAVID assisted training in Back Pain, sponsored by Medical University of Vienna.

Who is sponsoring NCT03393429?

NCT03393429 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT03393429?

Interventions in NCT03393429: DAVID assisted training, training recommendation.

What condition does NCT03393429 study?

NCT03393429 studies Back Pain, Lower Back Pain.

Is NCT03393429 still recruiting?

NCT03393429 is currently completed. Last updated 20 October 2020.

Last reviewed 2020-10-20 · How we verify

NCT03393429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Training Therapy for the Prevention of Back Pain

Completed NA Last updated 20 October 2020

What this trial tests

NA trial testing DAVID assisted training in Back Pain in 33 participants. Completed in 1 February 2019.

Timeline

1 November 2017

Primary endpoint
1 November 2018

1 February 2019

Quick facts

Lead sponsor	Medical University of Vienna
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	33
Start date	1 November 2017
Primary completion	1 November 2018
Estimated completion	1 February 2019
Sites	1 location across Austria

Drugs / interventions tested

DAVID assisted training
training recommendation

Conditions studied

Back Pain — all drugs for Back Pain →
Lower Back Pain — all drugs for Lower Back Pain →

Sponsor

Medical University of Vienna

Who can join

Adults 45 to 65, any sex, with Back Pain or Lower Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Work place related (lower) back pain in medical personnel is limiting to workability. Even though occupational prevention programs are increasingly established, data on the effectiveness of training interventions offered at work-sites is largely missing. In this randomized, investigator-blind, controlled feasibility study we aim to compare the effectiveness of device assisted training therapy in comparison to a general recommendation "to stay active" or group gymnastics in terms of pain frequency and intensity (main outcome). Additional outcome variables are: quality of life, psychological well-being, work efficiency, of sick-leave days. Eligible employees (2 x 30) of the General Hospital of Vienna (AKH) over the age of 45 years suffering from (lower) back pain (\>30 days/last year) of intensity ≥ 3 (numeric scale 0-10) will be included in two parallel groups. Group I starts with a device (DAVID) assisted training (40 training sessions; 2x / week) of the core trunk musculature. Group II gets instructions and an advice on how to "stay active" during the first 6 months. Assessment will be conducted before and after these 6 months; then groups are switched, thus, study subjects act as their own controls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Back Pain

Currently open trials in the same condition.

NCT07588490 — Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments · NA · recruiting
NCT07292350 — Investigation of the Effects of a Neuromuscular Control-Focused Posture Training Program in Butchers · NA · recruiting
NCT07319988 — Effect of Shock Wave Therapy With Core Stability Exercises for Treatment of Chronic Non-Specific Back Pain · NA · recruiting
NCT06655337 — Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU) · NA · recruiting
NCT07104227 — Effects of Body Mechanics Training on Shoulder-Back Pain and Breastfeeding Ergonomics in Breastfeeding Mothers · NA · active not recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393429 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 20 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing